Pacira BioSciences, Inc. - COM (PCRX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
48.1 M
Holdings value Q1 2024
$1.41 B
Value change Q1 2024
+$15 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
253
Number of buys Q1 2024
126
Number of sells Q1 2024
-104
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.001%
CUSIP
695127100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 48.1 M $1.41 B +$15 M $29.22 253
2023 Q4 47.5 M $1.6 B -$4.14 M $33.74 249
2023 Q3 46.8 M $1.44 B -$4.93 M $30.68 247
2023 Q2 46.4 M $1.86 B +$9.97 M $40.07 246
2023 Q1 46.2 M $1.89 B -$75 M $40.81 261
2022 Q4 48.3 M $1.86 B -$48.6 M $38.61 261
2022 Q3 46.7 M $2.48 B +$82.3 M $53.19 249
2022 Q2 48.8 M $2.84 B -$35.7 M $58.30 266
2022 Q1 49.5 M $3.77 B -$68 M $76.32 284
2021 Q4 50.5 M $3.04 B +$80.6 M $60.17 259
2021 Q3 49.1 M $2.75 B -$7.82 M $56.00 251
2021 Q2 49.2 M $2.98 B -$36.5 M $60.68 253
2021 Q1 49.8 M $3.49 B -$29 M $70.09 266
2020 Q4 50.3 M $3.01 B +$131 M $59.84 254
2020 Q3 48.2 M $2.9 B -$13.4 M $60.12 250
2020 Q2 48.7 M $2.56 B +$107 M $52.47 240
2020 Q1 46.8 M $1.57 B +$37.7 M $33.53 211
2019 Q4 45.3 M $2.05 B +$15.6 M $45.30 225
2019 Q3 45.1 M $1.72 B +$75.6 M $38.07 206
2019 Q2 42.8 M $1.86 B +$131 M $43.49 214
2019 Q1 41.3 M $1.57 B +$30 M $38.06 202
2018 Q4 39.8 M $1.71 B -$35.2 M $43.02 196
2018 Q3 40.4 M $1.98 B -$82.9 M $49.15 182
2018 Q2 42.4 M $1.36 B -$4.23 M $32.05 147
2018 Q1 43.6 M $1.36 B +$18.5 M $31.15 161
2017 Q4 41.5 M $1.9 B -$63.9 M $45.65 179
2017 Q3 43.5 M $1.63 B +$59.8 M $37.55 176
2017 Q2 41 M $1.96 B +$8.54 M $47.70 191
2017 Q1 40.9 M $1.87 B +$210 M $45.60 189
2016 Q4 39.9 M $1.29 B +$17.8 M $32.30 179
2016 Q3 39.4 M $1.35 B -$48.8 M $34.22 176
2016 Q2 40.7 M $1.37 B -$219 M $33.73 181
2016 Q1 42.9 M $2.27 B -$34 M $52.98 174
2015 Q4 42 M $3.23 B +$16.6 M $76.79 206
2015 Q3 41.7 M $1.71 B -$38.7 M $41.10 174
2015 Q2 42.4 M $3 B +$147 M $70.72 185
2015 Q1 40.2 M $3.58 B +$97.5 M $88.85 203
2014 Q4 37.9 M $3.36 B -$15.2 M $88.66 196
2014 Q3 38.4 M $3.72 B +$110 M $96.92 205
2014 Q2 37.4 M $3.43 B +$245 M $91.86 188
2014 Q1 34.9 M $2.44 B +$23.2 M $69.99 157